Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.

Identifieur interne : 002272 ( PubMed/Checkpoint ); précédent : 002271; suivant : 002273

Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.

Auteurs : Jamie C. Zampell [États-Unis] ; Alan Yan ; Tomer Avraham ; Victor Andrade ; Stephanie Malliaris ; Seth Aschen ; Stanley G. Rockson ; Babak J. Mehrara

Source :

RBID : pubmed:21248077

Descripteurs français

English descriptors

Abstract

While acute tissue injury potently induces endogenous danger signal expression, the role of these molecules in chronic wound healing and lymphedema is undefined. The purpose of this study was to determine the spatial and temporal expression patterns of the endogenous danger signals high-mobility group box 1 (HMGB1) and heat shock protein (HSP)70 during wound healing and chronic lymphatic fluid stasis. In a surgical mouse tail model of tissue injury and lymphedema, HMGB1 and HSP70 expression occurred along a spatial gradient relative to the site of injury, with peak expression at the wound and greater than twofold reduced expression within 5 mm (P < 0.05). Expression primarily occurred in cells native to injured tissue. In particular, HMGB1 was highly expressed by lymphatic endothelial cells (>40% positivity; twofold increase in chronic inflammation, P < 0.001). We found similar findings using a peritoneal inflammation model. Interestingly, upregulation of HMGB1 (2.2-fold), HSP70 (1.4-fold), and nuclear factor (NF)-κβ activation persisted at least 6 wk postoperatively only in lymphedematous tissues. Similarly, we found upregulation of endogenous danger signals in soft tissue of the arm after axillary lymphadenectomy in a mouse model and in matched biopsy samples obtained from patients with secondary lymphedema comparing normal to lymphedematous arms (2.4-fold increased HMGB1, 1.9-fold increased HSP70; P < 0.01). Finally, HMGB1 blockade significantly reduced inflammatory lymphangiogenesis within inflamed draining lymph nodes (35% reduction, P < 0.01). In conclusion, HMGB1 and HSP70 are expressed along spatial gradients and upregulated in chronic lymphatic fluid stasis. Furthermore, acute expression of endogenous danger signals may play a role in inflammatory lymphangiogenesis.

DOI: 10.1152/ajpcell.00378.2010
PubMed: 21248077


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:21248077

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.</title>
<author>
<name sortKey="Zampell, Jamie C" sort="Zampell, Jamie C" uniqKey="Zampell J" first="Jamie C" last="Zampell">Jamie C. Zampell</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yan, Alan" sort="Yan, Alan" uniqKey="Yan A" first="Alan" last="Yan">Alan Yan</name>
</author>
<author>
<name sortKey="Avraham, Tomer" sort="Avraham, Tomer" uniqKey="Avraham T" first="Tomer" last="Avraham">Tomer Avraham</name>
</author>
<author>
<name sortKey="Andrade, Victor" sort="Andrade, Victor" uniqKey="Andrade V" first="Victor" last="Andrade">Victor Andrade</name>
</author>
<author>
<name sortKey="Malliaris, Stephanie" sort="Malliaris, Stephanie" uniqKey="Malliaris S" first="Stephanie" last="Malliaris">Stephanie Malliaris</name>
</author>
<author>
<name sortKey="Aschen, Seth" sort="Aschen, Seth" uniqKey="Aschen S" first="Seth" last="Aschen">Seth Aschen</name>
</author>
<author>
<name sortKey="Rockson, Stanley G" sort="Rockson, Stanley G" uniqKey="Rockson S" first="Stanley G" last="Rockson">Stanley G. Rockson</name>
</author>
<author>
<name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J" last="Mehrara">Babak J. Mehrara</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21248077</idno>
<idno type="pmid">21248077</idno>
<idno type="doi">10.1152/ajpcell.00378.2010</idno>
<idno type="wicri:Area/PubMed/Corpus">002770</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002770</idno>
<idno type="wicri:Area/PubMed/Curation">002770</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002770</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002770</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002770</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.</title>
<author>
<name sortKey="Zampell, Jamie C" sort="Zampell, Jamie C" uniqKey="Zampell J" first="Jamie C" last="Zampell">Jamie C. Zampell</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yan, Alan" sort="Yan, Alan" uniqKey="Yan A" first="Alan" last="Yan">Alan Yan</name>
</author>
<author>
<name sortKey="Avraham, Tomer" sort="Avraham, Tomer" uniqKey="Avraham T" first="Tomer" last="Avraham">Tomer Avraham</name>
</author>
<author>
<name sortKey="Andrade, Victor" sort="Andrade, Victor" uniqKey="Andrade V" first="Victor" last="Andrade">Victor Andrade</name>
</author>
<author>
<name sortKey="Malliaris, Stephanie" sort="Malliaris, Stephanie" uniqKey="Malliaris S" first="Stephanie" last="Malliaris">Stephanie Malliaris</name>
</author>
<author>
<name sortKey="Aschen, Seth" sort="Aschen, Seth" uniqKey="Aschen S" first="Seth" last="Aschen">Seth Aschen</name>
</author>
<author>
<name sortKey="Rockson, Stanley G" sort="Rockson, Stanley G" uniqKey="Rockson S" first="Stanley G" last="Rockson">Stanley G. Rockson</name>
</author>
<author>
<name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J" last="Mehrara">Babak J. Mehrara</name>
</author>
</analytic>
<series>
<title level="j">American journal of physiology. Cell physiology</title>
<idno type="eISSN">1522-1563</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Chronic Disease</term>
<term>Endothelial Cells (physiology)</term>
<term>Female</term>
<term>HMGB1 Protein (biosynthesis)</term>
<term>HMGB1 Protein (physiology)</term>
<term>HSP70 Heat-Shock Proteins (biosynthesis)</term>
<term>HSP70 Heat-Shock Proteins (physiology)</term>
<term>Humans</term>
<term>Inflammation (physiopathology)</term>
<term>Lymphatic System (pathology)</term>
<term>Lymphatic System (physiopathology)</term>
<term>Lymphedema (pathology)</term>
<term>Lymphedema (physiopathology)</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>NF-kappa B (biosynthesis)</term>
<term>NF-kappa B (physiology)</term>
<term>Peritonitis (pathology)</term>
<term>Peritonitis (physiopathology)</term>
<term>Signal Transduction (physiology)</term>
<term>Up-Regulation (physiology)</term>
<term>Wound Healing (physiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules endothéliales (physiologie)</term>
<term>Cicatrisation de plaie (physiologie)</term>
<term>Facteur de transcription NF-kappa B (biosynthèse)</term>
<term>Facteur de transcription NF-kappa B (physiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inflammation (physiopathologie)</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Lymphoedème (physiopathologie)</term>
<term>Maladie chronique</term>
<term>Protéine HMGB1 (biosynthèse)</term>
<term>Protéine HMGB1 (physiologie)</term>
<term>Protéines du choc thermique HSP70 (biosynthèse)</term>
<term>Protéines du choc thermique HSP70 (physiologie)</term>
<term>Péritonite (anatomopathologie)</term>
<term>Péritonite (physiopathologie)</term>
<term>Régulation positive (physiologie)</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Système lymphatique (anatomopathologie)</term>
<term>Système lymphatique (physiopathologie)</term>
<term>Transduction du signal (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>HMGB1 Protein</term>
<term>HSP70 Heat-Shock Proteins</term>
<term>NF-kappa B</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Lymphoedème</term>
<term>Péritonite</term>
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Facteur de transcription NF-kappa B</term>
<term>Protéine HMGB1</term>
<term>Protéines du choc thermique HSP70</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lymphatic System</term>
<term>Lymphedema</term>
<term>Peritonitis</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Cellules endothéliales</term>
<term>Cicatrisation de plaie</term>
<term>Facteur de transcription NF-kappa B</term>
<term>Protéine HMGB1</term>
<term>Protéines du choc thermique HSP70</term>
<term>Régulation positive</term>
<term>Transduction du signal</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Endothelial Cells</term>
<term>HMGB1 Protein</term>
<term>HSP70 Heat-Shock Proteins</term>
<term>NF-kappa B</term>
<term>Signal Transduction</term>
<term>Up-Regulation</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Inflammation</term>
<term>Lymphoedème</term>
<term>Péritonite</term>
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Inflammation</term>
<term>Lymphatic System</term>
<term>Lymphedema</term>
<term>Peritonitis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Chronic Disease</term>
<term>Female</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladie chronique</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">While acute tissue injury potently induces endogenous danger signal expression, the role of these molecules in chronic wound healing and lymphedema is undefined. The purpose of this study was to determine the spatial and temporal expression patterns of the endogenous danger signals high-mobility group box 1 (HMGB1) and heat shock protein (HSP)70 during wound healing and chronic lymphatic fluid stasis. In a surgical mouse tail model of tissue injury and lymphedema, HMGB1 and HSP70 expression occurred along a spatial gradient relative to the site of injury, with peak expression at the wound and greater than twofold reduced expression within 5 mm (P < 0.05). Expression primarily occurred in cells native to injured tissue. In particular, HMGB1 was highly expressed by lymphatic endothelial cells (>40% positivity; twofold increase in chronic inflammation, P < 0.001). We found similar findings using a peritoneal inflammation model. Interestingly, upregulation of HMGB1 (2.2-fold), HSP70 (1.4-fold), and nuclear factor (NF)-κβ activation persisted at least 6 wk postoperatively only in lymphedematous tissues. Similarly, we found upregulation of endogenous danger signals in soft tissue of the arm after axillary lymphadenectomy in a mouse model and in matched biopsy samples obtained from patients with secondary lymphedema comparing normal to lymphedematous arms (2.4-fold increased HMGB1, 1.9-fold increased HSP70; P < 0.01). Finally, HMGB1 blockade significantly reduced inflammatory lymphangiogenesis within inflamed draining lymph nodes (35% reduction, P < 0.01). In conclusion, HMGB1 and HSP70 are expressed along spatial gradients and upregulated in chronic lymphatic fluid stasis. Furthermore, acute expression of endogenous danger signals may play a role in inflammatory lymphangiogenesis.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21248077</PMID>
<DateCreated>
<Year>2011</Year>
<Month>04</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>07</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>02</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1522-1563</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>300</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2011</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Cell physiology</Title>
<ISOAbbreviation>Am. J. Physiol., Cell Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.</ArticleTitle>
<Pagination>
<MedlinePgn>C1107-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpcell.00378.2010</ELocationID>
<Abstract>
<AbstractText>While acute tissue injury potently induces endogenous danger signal expression, the role of these molecules in chronic wound healing and lymphedema is undefined. The purpose of this study was to determine the spatial and temporal expression patterns of the endogenous danger signals high-mobility group box 1 (HMGB1) and heat shock protein (HSP)70 during wound healing and chronic lymphatic fluid stasis. In a surgical mouse tail model of tissue injury and lymphedema, HMGB1 and HSP70 expression occurred along a spatial gradient relative to the site of injury, with peak expression at the wound and greater than twofold reduced expression within 5 mm (P < 0.05). Expression primarily occurred in cells native to injured tissue. In particular, HMGB1 was highly expressed by lymphatic endothelial cells (>40% positivity; twofold increase in chronic inflammation, P < 0.001). We found similar findings using a peritoneal inflammation model. Interestingly, upregulation of HMGB1 (2.2-fold), HSP70 (1.4-fold), and nuclear factor (NF)-κβ activation persisted at least 6 wk postoperatively only in lymphedematous tissues. Similarly, we found upregulation of endogenous danger signals in soft tissue of the arm after axillary lymphadenectomy in a mouse model and in matched biopsy samples obtained from patients with secondary lymphedema comparing normal to lymphedematous arms (2.4-fold increased HMGB1, 1.9-fold increased HSP70; P < 0.01). Finally, HMGB1 blockade significantly reduced inflammatory lymphangiogenesis within inflamed draining lymph nodes (35% reduction, P < 0.01). In conclusion, HMGB1 and HSP70 are expressed along spatial gradients and upregulated in chronic lymphatic fluid stasis. Furthermore, acute expression of endogenous danger signals may play a role in inflammatory lymphangiogenesis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zampell</LastName>
<ForeName>Jamie C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yan</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Avraham</LastName>
<ForeName>Tomer</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Andrade</LastName>
<ForeName>Victor</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Malliaris</LastName>
<ForeName>Stephanie</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Aschen</LastName>
<ForeName>Seth</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rockson</LastName>
<ForeName>Stanley G</ForeName>
<Initials>SG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mehrara</LastName>
<ForeName>Babak J</ForeName>
<Initials>BJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>01</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Cell Physiol</MedlineTA>
<NlmUniqueID>100901225</NlmUniqueID>
<ISSNLinking>0363-6143</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018840">HSP70 Heat-Shock Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2002 Apr 12;296(5566):301-5</RefSource>
<PMID Version="1">11951032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2009 Dec;175(6):2454-62</RefSource>
<PMID Version="1">19850888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2002 Oct;3(10):995-1001</RefSource>
<PMID Version="1">12231511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2003 Apr 18;92(7):801-8</RefSource>
<PMID Version="1">12623882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scand J Infect Dis. 2003;35(9):577-84</RefSource>
<PMID Version="1">14620138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2004 Feb 2;164(3):441-9</RefSource>
<PMID Version="1">14744997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Feb 27;279(9):7370-7</RefSource>
<PMID Version="1">14660645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2004 Jul 1;173(1):307-13</RefSource>
<PMID Version="1">15210788</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2004 Aug 15;104(4):1174-82</RefSource>
<PMID Version="1">15130941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Pharmacol. 2004 Sep 15;68(6):1165-70</RefSource>
<PMID Version="1">15313414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1995 Oct 27;270(43):25752-61</RefSource>
<PMID Version="1">7592757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 1998 Nov;102(6):1805-17; discussion 1818-20</RefSource>
<PMID Version="1">9810974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2776-81</RefSource>
<PMID Version="1">9874397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1999 Jul 9;285(5425):248-51</RefSource>
<PMID Version="1">10398600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scand J Immunol. 2004 Dec;60(6):566-73</RefSource>
<PMID Version="1">15584967</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scand J Immunol. 2005 Jan;61(1):1-9</RefSource>
<PMID Version="1">15644117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2005 Dec 1;175(11):7661-8</RefSource>
<PMID Version="1">16301676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2006 Feb 24;124(4):783-801</RefSource>
<PMID Version="1">16497588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2006 Jun 15;176(12):7154-8</RefSource>
<PMID Version="1">16751357</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2006 Jul 10;203(7):1637-42</RefSource>
<PMID Version="1">16818669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2006 Jul;3(7):e254</RefSource>
<PMID Version="1">16834456</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2006 Dec 1;177(11):7889-97</RefSource>
<PMID Version="1">17114460</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2006 Dec;20(14):2565-6</RefSource>
<PMID Version="1">17060403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 2007 Jan;81(1):92-9</RefSource>
<PMID Version="1">16997859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 2007 Jan;81(1):1-5</RefSource>
<PMID Version="1">17032697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2007 Feb 2;100(2):204-12</RefSource>
<PMID Version="1">17218606</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Biol. 2007 Apr;14(4):345-7</RefSource>
<PMID Version="1">17462568</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Biol. 2007 Apr;14(4):431-41</RefSource>
<PMID Version="1">17462578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cardiovasc Pathol. 2007 May-Jun;16(3):136-43</RefSource>
<PMID Version="1">17502242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 2007 Aug;82(2):282-5</RefSource>
<PMID Version="1">17495051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurochem. 2007 Oct;103(2):590-603</RefSource>
<PMID Version="1">17666052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1538-44</RefSource>
<PMID Version="1">17652366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Invest Dermatol. 2010 Apr;130(4):1167-77</RefSource>
<PMID Version="1">19727116</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Immunol. 2010;28:367-88</RefSource>
<PMID Version="1">20192808</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Immunol. 2010;28:321-42</RefSource>
<PMID Version="1">20307211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Transfus Med Rev. 2010 Jul;24(3):218-34</RefSource>
<PMID Version="1">20656189</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mediators Inflamm. 2010;2010. pii: 672395. doi: 10.1155/2010/672395</RefSource>
<PMID Version="1">20706656</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2010 Dec;177(6):3202-14</RefSource>
<PMID Version="1">21056998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2007 Oct 8;179(1):33-40</RefSource>
<PMID Version="1">17923528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Microbiol Immunol. 2008 Mar;197(1):1-8</RefSource>
<PMID Version="1">17638015</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2007 Dec;13(12):1458-66</RefSource>
<PMID Version="1">18059280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2007 Dec;171(6):1774-88</RefSource>
<PMID Version="1">17974599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2008 Mar 1;180(5):3399-405</RefSource>
<PMID Version="1">18292566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 2008 Mar;83(3):546-52</RefSource>
<PMID Version="1">18032691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Invest Dermatol. 2008 Jun;128(6):1545-53</RefSource>
<PMID Version="1">18239618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Res Ther. 2008;10(3):209</RefSource>
<PMID Version="1">18598385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 2008 Oct;39(4):440-7</RefSource>
<PMID Version="1">18441281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2113-27</RefSource>
<PMID Version="1">18849330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2009 Jan 13;6(1):e10</RefSource>
<PMID Version="1">19143470</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2009 May 28;113(22):5650-9</RefSource>
<PMID Version="1">19346498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2009 Jul;175(1):132-47</RefSource>
<PMID Version="1">19528348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2009 Aug;124(2):438-50</RefSource>
<PMID Version="1">19644258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Autoimmunity. 2009 May;42(4):299-301</RefSource>
<PMID Version="1">19811282</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2002 Jul 11;418(6894):191-5</RefSource>
<PMID Version="1">12110890</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D024243" MajorTopicYN="N">HMGB1 Protein</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018840" MajorTopicYN="N">HSP70 Heat-Shock Proteins</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008208" MajorTopicYN="N">Lymphatic System</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010538" MajorTopicYN="N">Peritonitis</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3093946</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>1</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>1</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>7</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21248077</ArticleId>
<ArticleId IdType="pii">ajpcell.00378.2010</ArticleId>
<ArticleId IdType="doi">10.1152/ajpcell.00378.2010</ArticleId>
<ArticleId IdType="pmc">PMC3093946</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>État de New York</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Andrade, Victor" sort="Andrade, Victor" uniqKey="Andrade V" first="Victor" last="Andrade">Victor Andrade</name>
<name sortKey="Aschen, Seth" sort="Aschen, Seth" uniqKey="Aschen S" first="Seth" last="Aschen">Seth Aschen</name>
<name sortKey="Avraham, Tomer" sort="Avraham, Tomer" uniqKey="Avraham T" first="Tomer" last="Avraham">Tomer Avraham</name>
<name sortKey="Malliaris, Stephanie" sort="Malliaris, Stephanie" uniqKey="Malliaris S" first="Stephanie" last="Malliaris">Stephanie Malliaris</name>
<name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J" last="Mehrara">Babak J. Mehrara</name>
<name sortKey="Rockson, Stanley G" sort="Rockson, Stanley G" uniqKey="Rockson S" first="Stanley G" last="Rockson">Stanley G. Rockson</name>
<name sortKey="Yan, Alan" sort="Yan, Alan" uniqKey="Yan A" first="Alan" last="Yan">Alan Yan</name>
</noCountry>
<country name="États-Unis">
<region name="État de New York">
<name sortKey="Zampell, Jamie C" sort="Zampell, Jamie C" uniqKey="Zampell J" first="Jamie C" last="Zampell">Jamie C. Zampell</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002272 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002272 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:21248077
   |texte=   Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:21248077" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024